Compounds > glucuronic acid
Page last updated: 2024-08-24

glucuronic acid and Diabetes Mellitus, Adult-Onset

glucuronic acid has been researched along with Diabetes Mellitus, Adult-Onset in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cózar-Bernal, MJ; Di Cesare Mannelli, L; Ghelardini, C; González-Rodríguez, ML; Maestrelli, F; Mura, P; Rabasco, AM1
Al-Salami, H; Al-Sallami, HS; Arfuso, F; Chen-Tan, N; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Matthews, V; Mikov, M; Mooranian, A; Mukkur, TK; Negrulj, R; Watts, GF1
Al-Salami, H; Arfuso, F; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Negrulj, R1
Formosa, C; Vassallo, IM1
Baker, AB; Das, S; Dunn, AK; Lam, B; Martin, PE; Monteforte, AJ; Mukhopadhyay, S; Wright, CS1
Kasacka, I; Lewandowska, A; Sosnowska, K; Szekalska, M; Winnicka, K; Zakrzeska, A1
Chen, W; Zeng, Q1
Jain, SK; Nayak, A; Pandey, RS1
Astrup, A; Georg Jensen, M; Kristensen, M1
Bresson, R; Charpentier, P; Coliche, V; Erlher, S; Ha Van, G; Lalau, JD; Magalon, G; Martini, J; Moreau, Y; Pradines, S; Richard, JL; Rigal, F; Wemeau, JL1
Gold, L; Merimee, TJ; Misbin, RI1
Alpsten, M; Holm, G; Sandberg, AS; Tölli, J; Torsdottir, I1

Trials

3 trial(s) available for glucuronic acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial.
    The American journal of clinical nutrition, 2012, Volume: 96, Issue:1

    Topics: Adiposity; Adult; Alginates; Anti-Obesity Agents; Beverages; Body Mass Index; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Fiber; Dietary Supplements; Double-Blind Method; Female; Glucuronic Acid; Hexuronic Acids; Humans; Insulin Resistance; Intention to Treat Analysis; Male; Middle Aged; Obesity; Obesity, Morbid; Patient Dropouts; Risk Factors; Weight Loss

2012
Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions.
    Diabetes & metabolism, 2002, Volume: 28, Issue:3

    Topics: Age of Onset; Alginates; Bandages; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Follow-Up Studies; France; Glucuronic Acid; Glycated Hemoglobin; Hexuronic Acids; Humans; Male; Middle Aged; Petrolatum; Time Factors; Treatment Outcome; Wound Healing

2002
A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes.
    The Journal of nutrition, 1991, Volume: 121, Issue:6

    Topics: Adult; Alginates; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Fiber; Gastric Emptying; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Male; Middle Aged; Solubility

1991

Other Studies

9 other study(ies) available for glucuronic acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus.
    International journal of pharmaceutics, 2017, Sep-15, Volume: 530, Issue:1-2

    Topics: Alginates; Animals; Diabetes Mellitus, Type 2; Glucuronic Acid; Hexuronic Acids; Liposomes; Male; Metformin; Microspheres; Particle Size; Rats; Rats, Sprague-Dawley

2017
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Administration, Oral; Alginates; Diabetes Mellitus, Type 2; Drug Compounding; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Probucol; Surface Properties

2014
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study.
    Journal of microencapsulation, 2015, Volume: 32, Issue:6

    Topics: Administration, Oral; Alginates; Bile Acids and Salts; Calorimetry, Differential Scanning; Capsules; Chenodeoxycholic Acid; Diabetes Mellitus, Type 2; Drug Compounding; Drug Delivery Systems; Drug Stability; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Particle Size; Powders; Probucol; Rheology; Spectroscopy, Fourier Transform Infrared; Surface Properties; Temperature; Viscosity; X-Ray Microtomography

2015
Comparing Calcium Alginate Dressings to Vacuum-assisted Closure: A Clinical Trial.
    Wounds : a compendium of clinical research and practice, 2015, Volume: 27, Issue:7

    Topics: Alginates; Bandages; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Glucuronic Acid; Hemostatics; Hexuronic Acids; Humans; Male; Middle Aged; Negative-Pressure Wound Therapy; Peripheral Arterial Disease; Peripheral Nervous System Diseases; Quality of Life; Wound Healing

2015
Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.
    Biomaterials, 2016, Volume: 94

    Topics: Alginates; Animals; Blood Vessels; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Delivery Systems; Endosomes; Fibroblast Growth Factor 2; Glucuronic Acid; Glypicans; HEK293 Cells; HeLa Cells; Hexuronic Acids; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Kinetics; Liposomes; Mice, Obese; Nanoparticles; Neovascularization, Physiologic; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin; Vascular Endothelial Growth Factor A

2016
The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation.
    Molecules (Basel, Switzerland), 2017, Jan-22, Volume: 22, Issue:1

    Topics: Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Kidney; Liver; Male; Metformin; Pancreas; Particle Size; Rats; Rats, Wistar; Streptozocin

2017
The functional behavior of a macrophage/fibroblast co-culture model derived from normal and diabetic mice with a marine gelatin-oxidized alginate hydrogel.
    Biomaterials, 2010, Volume: 31, Issue:22

    Topics: Alginates; Animals; Bandages, Hydrocolloid; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Type 2; Fibroblasts; Gelatin; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Macrophages; Male; Mice; Mice, Inbred C57BL; Tissue Scaffolds; Wound Healing

2010
Controlling release of metformin HCl through incorporation into stomach specific floating alginate beads.
    Molecular pharmaceutics, 2011, Dec-05, Volume: 8, Issue:6

    Topics: Alginates; Animals; Calorimetry, Differential Scanning; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Hypoglycemic Agents; Male; Metformin; Particle Size; Porosity; Rats; Rats, Sprague-Dawley; Stomach; Surface Properties

2011
Elevated L-xylulose concentrations in serum: a difference between type I and type II diabetes.
    Metabolism: clinical and experimental, 1984, Volume: 33, Issue:1

    Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucuronates; Glucuronic Acid; Growth Hormone; Humans; Inositol; Pentoses; Xylulose

1984